本报讯 （记者冯思婕）近日，工业和信息化部、国家发展改革委联合公示全国首批生物制造中试能力建设平台名单，全国 共有43家单位入选。由传化集团有限公司（以下简称"传化集团"）与国有资本合作建设运营的"杭州合成生物产业中试（验 证）中心"成功入选，成为浙江省代表性平台之一。这标志着传化集团在合成生物产业领域的技术实力与产业化能力获得国家 级权威认可。 名单公示/官网截图 | 中华人民共和国工业和信息化部 | ry and Information Technology of the People's Republic of China | | | | ● 阳光小信 无障碍 手机端 邮箱 请输入关键字 | | --- | --- | --- | --- | --- | --- | | (2 | 首页 组织机构 | 新闻发布 | 政务公开 | 政务服务 | 互动交流 T1 | | 首页 > 工业和信息化部 > 机关司局 > 消费品工业司 > 食品 | | | 4-1660 4:1 ) 446 -- 1 | | | | 序号 | 所在单位名称 | 主要服务领域 | 地址 | 联系电话 | 电子邮箱 | 用 | | --- ...

Core Insights - The article discusses the rapid development and investment in the biomanufacturing sector in China, highlighting various projects and initiatives aimed at establishing mid-test platforms across multiple regions [5][6][12]. Investment and Project Developments - In Chongqing, a total of 32 projects with an investment of 14.53 billion yuan were signed, focusing on biomanufacturing, biomedicine, and other high-tech industries [5]. - The Chongqing Biomanufacturing Industry Pilot Platform aims to create a national-level mid-test platform for biomanufacturing, emphasizing intelligent biological fermentation and related technologies [6]. - The platform is part of a broader initiative that includes 1,252 key projects with a total investment of approximately 3.2 trillion yuan planned for 2025 [6]. Regional Initiatives - Changde Economic Development Zone is also advancing its synthetic biomanufacturing mid-test conversion platform, with significant construction progress reported [7][8]. - The Changde platform has a total investment of 169 million yuan and will feature multiple mid-test production lines to cater to various scales and types of biomanufacturing [8]. National Support and Policy Framework - Multiple provinces, including Guangdong, Shanghai, and Sichuan, are actively supporting the establishment of mid-test platforms, with specific funding and policy frameworks in place [10][11][12]. - The Ministry of Industry and Information Technology and the National Development and Reform Commission have set a goal to cultivate over 20 mid-test capability construction platforms by 2027, aiming to serve more than 200 enterprises [12].